| Financial Year |
March 31 2023 |
| Monetary Funds |
129,729,743.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,097,198.40 |
| Accounts Receivable |
82,955,232.24 |
| Advances to Suppliers |
10,689,793.64 |
| Other Receivables |
167,169,234.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
272,133,303.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,810,708.89 |
| Total Current Assets |
675,585,214.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,734,524.47 |
| Fixed Assetes |
302,442,187.54 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,216,301.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,538,175.93 |
| Deferred Income Tax Assets |
21,157,907.17 |
| Other Non-Current Assets |
130,239,594.00 |
| Sub-Total of Non-Current Assets |
532,502,258.86 |
| Total Assets |
1,208,087,472.93 |
| Short-Term Loans |
75,743,908.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
111,319,183.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,542,263.01 |
| Taxes Payable |
12,144,734.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
54,122,229.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,012,078.00 |
| Other Current Liabilities |
5,335,741.05 |
| Sub-Total of Current Liabilities |
280,553,064.05 |
| Long-term Loans |
15,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,657,652.67 |
| Total Liabilities |
316,210,716.72 |
| Paid-In Capital(Or Share Stock) |
438,850,000.00 |
| Capital Surplus |
1,244,485,586.83 |
| Surplus Reserve |
41,301,752.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-853,783,622.22 |
| Minority Stockholder's Interest |
14,782,929.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
877,093,826.99 |
| Owner's Equity（Stockholder's Equity） |
891,876,756.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,208,087,472.93 |
